Revlimid (lenalidomide) — Medica
Follicular lymphoma
Initial criteria
- age ≥ 18 years
- Lenalidomide used in combination with rituximab OR in combination with Gazyva (obinutuzumab) OR patient has tried at least one other regimen
Approval duration
1 year